Syneos Health has announced a partnership with Ride Health to offer non-emergency medical transportation (NEMT) to clinical trial participants. The collaboration, built on product integration between Ride Health and the Syneos Health patient engagement platform, will enable a comprehensive transportation program for Syneos Health trials in the U.S., with a goal of expanding access. Additionally, Syneos Health made a minority investment in Ride Health as part of the strategic relationship.
Ride Health’s national transportation network integrates ride-hailing services, taxi aggregators, and higher-touch NEMT operators to provide transportation across a trial’s multi-state site footprint. The platform matches each patient’s needs to the appropriate transportation mode across standard curbside pickup, door-to-door assistance, and wheelchair accessible vehicles. Ride Health’s solution then directly connects each stakeholder through its automated communication and support systems, allowing Syneos Health to reduce the coordination burden for site staff.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.